A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive Effects
Drummond E-Wen Mcculloch, Maria Zofia Grzywacz, M. Madsen, P.s. Jensen, Brice Ozenne, Sophia Armand, Gitte M. Knudsen, Patrick M. Fisher, Dea Siggard Stenbæk
December 14, 2021 preprint DOI: 10.31234/osf.io/xqzu2 via OpenAlex
Summary
AI-generated from the abstractPsilocybin, a psychedelic drug, can produce lasting positive psychological changes in healthy people. In 35 sessions with 28 healthy volunteers, those who reported more intense mystical experiences—measured by the Mystical Experience Questionnaire—were more likely to report positive effects three months later. The subscales 'Positive Mood' and 'Mysticality' predicted these benefits, while 'Transcendence of Time and Space' and 'Ineffability' did not. Qualitative reports described themes of connection with the universe, familial love, and profound beauty. The type of acute experience appears important for predicting lasting positive outcomes.
Study at a glance
| Characteristics | Observational cohort Qualitative |
|---|---|
| Sample size | 28 |
| Population | Healthy volunteers |
| Intervention | Psilocybin |
| Dose | medium-high doses |
| Duration | Three-month follow-up |
| Topics | Psilocybin |
| Keywords | Clinical psychology Mood Qualitative research Developmental psychology |
| Citations | 2 |
| Key finding | The intensity of mystical experience during psilocybin sessions, particularly the Positive Mood and Mysticality components, predicts positive persisting effects three months later. |
Abstract
Psychedelic drugs such as psilocybin are under investigation for the treatment of several psychiatric conditions. They also have the remarkable property of producing persisting positive psychological changes in healthy volunteers for at least several months. In this study, 35 medium-high doses of psilocybin were administered to 28 healthy volunteers (12 females). By the end of the dosing day, participants reported the intensity of their acute experience using the 30-item Mystical Experience Questionnaire (MEQ) and an open-form qualitative report from home. Persisting psychological effects attributed to the psilocybin experience were measured using the Persisting Effects Questionnaire (PEQ) three-months after administration. Using a linear latent-variable model we show that the MEQ total score is positively associated with the later emergence of positive PEQ effects (p = 3x10-5). Moreover, the MEQ subscales “Positive Mood” (pcorr = 4.1x10-4) and “Mysticality” (pcorr = 2.0x10-4) are associated with positive PEQ whereas the subscales “Transcendence of Time and Space” (pcorr = 0.38) and “Ineffability” (pcorr = 0.45) are not. Using natural language pre-processing, we provide the first qualitative descriptions of the “Complete Mystical Experience” induced by orally administered psilocybin in healthy volunteers, revealing themes such as a sense of connection with the universe, familial love, and the experience of profound beauty. Combining qualitative and quantitative methods, this paper expands understanding of the acute psilocybin induced experience in healthy volunteers and suggests an importance of the type of experience in predicting lasting positive effects.